Clinical Trials Directory

Trials / Completed

CompletedNCT01168492

Analgesia During Pediatric Digestive Endoscopy: a Comparison of Two Protocols for Procedural Sedation

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Université de Montréal · Academic / Other
Sex
All
Age
10 Years – 19 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether ketamine, midazolam, and meperidine are more effective than midazolam and meperidine alone for procedural sedation and analgesia in pediatric digestive endoscopy. Secondary outcomes are the incidence of cardiorespiratory side effects and the necessity of rescue doses.

Detailed description

90 patients will be included. The sedation will include 0.1mg/kg, max 5mg iv of midazolam, 1mg/kg, max 50mg iv of meperidine, and placebo (0.9%NaCl) or ketamine 0.5mg/kg iv. Rescue doses will be given as usual, using meperidine and or midazolam 50% of the initial dose.

Conditions

Interventions

TypeNameDescription
DRUGketamine0.5mg/kg ketamine iv

Timeline

Start date
2010-07-01
Primary completion
2013-07-01
Completion
2013-07-01
First posted
2010-07-23
Last updated
2014-12-04

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01168492. Inclusion in this directory is not an endorsement.

Analgesia During Pediatric Digestive Endoscopy: a Comparison of Two Protocols for Procedural Sedation (NCT01168492) · Clinical Trials Directory